Status:
COMPLETED
Cognitive Impairement In Frontotemporal Dementia
Lead Sponsor:
University of Pennsylvania
Conditions:
Frontotemporal Degeneration
Progressive Supranuclear Palsy
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational study that aims to better understand the genetic causes of frontotemporal degeneration (FTD), Multiple Systems Atrophy (MSA), and Progressive Supranuclear Palsy (PSP). It is h...
Detailed Description
Comparative and longitudinal studies reveal clinical differences between subgroups of patients with frontotemporal dementia (FTD), including Progressive Non-fluent Aphasia (PNFA), Semantic Dementia (S...
Eligibility Criteria
Inclusion
- Individuals who have been diagnosed with FTD, PSP, and MSA
Exclusion
- Individuals under 18 years of age
- People with pacemakers or certain metallic implants
- pregnant women
Key Trial Info
Start Date :
July 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 15 2020
Estimated Enrollment :
997 Patients enrolled
Trial Details
Trial ID
NCT03452956
Start Date
July 1 2003
End Date
July 15 2020
Last Update
November 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104